Clin2
NCT04049331Possibly a fitRecruiting

Testosterone therapy for cancer survivors with fatigue

Hypogonadism, MaleFatigue Syndrome, Chronic

Treatments studied

Part of Bones, joints & muscles, Brain & nervous system, Hormones & metabolism clinical trials.

This trial tests whether testosterone replacement can help male cancer survivors who have ongoing fatigue and low testosterone levels. It is for men who have completed chemotherapy or radiation and are cancer-free for at least a year.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
240 people
Ages
18 years to 54 years
Study type
Interventional

Who can take part

  • You are a male cancer survivor between 18 and 54 years old.
  • You had chemotherapy or radiation and have been in remission for at least 1 year.
  • Your cancer type does not depend on hormones (not breast, prostate, or unknown origin).
  • You have low testosterone based on a blood test.
  • You feel fatigued, as measured by a standard fatigue questionnaire.
  • You are not currently using testosterone, growth hormone, or certain other medications.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07278362Not yet recruiting· Phase 4
Testosterone therapy for men with low-risk prostate cancer on active surveillance

This study tests whether testosterone replacement therapy can safely improve low testosterone symptoms in men with low-risk prostate cancer who are not receiving active treatment. You may be eligible if you have confirmed low testosterone and are being monitored without intervention.

Miami, Florida
NCT07768917Not yet recruiting
Exercise training to manage side effects of prostate cancer treatment

This study tests whether a structured exercise program can help you manage side effects from hormone therapy and radiation for prostate cancer. It aims to improve your overall well-being.

Boston, Massachusetts
NCT07143279Recruiting· Early Phase 1
Testosterone for quality of life in men with advanced cancer

This trial tests if testosterone supplements can improve quality of life for men with low testosterone who are no longer receiving active cancer treatment. It aims to help with symptoms like fatigue and low mood.

Brussels
NCT05664009Not yet recruiting
Testing Redsenol-1 Plus for cancer-related fatigue

This trial tests a natural supplement for fatigue in cancer survivors. You must have had fatigue for at least a month and be otherwise stable.

London, Ontario
NCT06733350Recruiting· Phase 4
Testosterone therapy for low testosterone in men with low-risk prostate cancer

This study tests whether testosterone replacement therapy can safely improve low testosterone levels in men with low-risk prostate cancer who are not getting immediate treatment. It aims to help men feel better without worsening their cancer.

Buffalo, New York
NCT06085716Recruiting· Phase 2/Phase 3
Combination therapy for advanced cancer fatigue

This study tests a combination of treatments (including education and counseling) to see if they can reduce severe fatigue in people with advanced cancer. It's for patients who are seen at MD Anderson Cancer Center in Texas and can attend sessions in person or online.

Houston, Texas

Hear when a new Hypogonadism, Male trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.